U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Johnson & Johnson

Market Cap: US$624.7b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Bristol-Myers Squibb

Market Cap: US$132.2b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Zoetis

Market Cap: US$30.0b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Pfizer

Market Cap: US$152.5b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Amgen

Market Cap: US$222.2b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Merck

Market Cap: US$317.2b

Operates as a healthcare company worldwide.

AbbVie

Market Cap: US$434.8b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Phibro Animal Health

Market Cap: US$1.4b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Agilent Technologies

Market Cap: US$41.2b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Gilead Sciences

Market Cap: US$165.2b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Danaher

Market Cap: US$143.9b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Viatris

Market Cap: US$18.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Royalty Pharma

Market Cap: US$32.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Qiagen

Market Cap: US$8.7b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

AnaptysBio

Market Cap: US$1.7b

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.

Hisamitsu Pharmaceutical

Market Cap: US$8.2b

Manufactures and sells pharmaceuticals in Japan.

Alnylam Pharmaceuticals

Market Cap: US$29.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Organon

Market Cap: US$3.6b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

Septerna

Market Cap: US$1.8b

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

ACADIA Pharmaceuticals

Market Cap: US$5.0b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Adaptive Biotechnologies

Market Cap: US$4.0b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

BioLife Solutions

Market Cap: US$1.7b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Trevi Therapeutics

Market Cap: US$2.6b

A clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

Axsome Therapeutics

Market Cap: US$10.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Revolution Medicines

Market Cap: US$44.0b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Trulieve Cannabis

Market Cap: US$1.7b

Operates as a cannabis retailer in the United States.

Tempus AI

Market Cap: US$8.3b

Operates as a healthcare technology company in the United States.

Avantor

Market Cap: US$9.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Braveheart Bio

Market Cap: US$1.9b

A clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.

Halozyme Therapeutics

Market Cap: US$11.7b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

Biogen

Market Cap: US$30.5b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Dianthus Therapeutics

Market Cap: US$6.1b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

Olema Pharmaceuticals

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Kodiak Sciences

Market Cap: US$2.8b

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Madrigal Pharmaceuticals

Market Cap: US$11.8b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.